Given the fact that global deletion of Asxl1 results in biased myeloid differentiation, we questioned that Asxl1-deficient niche may alter the cell fates of HSC/HPCs, contributing to the pathogenesis of myeloid malignancies. This evidence concerns the gene ASXL1 and myeloid neoplasm.